Keyphrases
Burkitt Lymphoma
100%
C-Myc
62%
CDKN1A
12%
CDKN2B
12%
Cell Cycle Arrest
12%
Cyclin-dependent Kinase Inhibitor
12%
Cytostasis
25%
Cytostatic
12%
Deregulation
12%
Derepression
12%
E2F Transcription Factor 1 (E2F1)
100%
G1 Arrest
12%
Growth Arrest
100%
Growth Factors
12%
Lung Epithelial Cells
12%
Lymphoma Cells
12%
Major Components
12%
Mammary Epithelial Cells
12%
Mediated Growth
12%
MYC Expression
25%
Overexpression
12%
Pivotal Events
12%
Skin Epithelial Cells
12%
Tissue Homeostasis
12%
Transcriptional Repression
100%
Transforming Growth Factor-β
100%
Transforming Growth Factor-β Signaling
12%
Tumor Promoter
12%
Tumor Suppressor
12%
Tumor Suppressor Activity
25%
Biochemistry, Genetics and Molecular Biology
CDKN2B
12%
Cell Cycle Arrest
12%
Cell Cycle Checkpoint
12%
Cyclin-Dependent Kinase
12%
Cytostasis
25%
Derepression
12%
E2F
100%
Homeostasis
12%
P21
25%
Promoter Region
12%
Transcription
12%
Transforming Growth Factor Beta
100%
Transforming Growth Factor Beta Induced
12%
Tumor Suppressor Protein
37%
Pharmacology, Toxicology and Pharmaceutical Science
Burkitt's Lymphoma
100%
Cyclin Dependent Kinase Inhibitor
11%
Cytostatic Agent
11%
Growth Disorder
100%
Growth Promotor
11%
Transforming Growth Factor Beta
100%
Tumor Promoter
11%
Tumor Suppressor Protein
33%
Immunology and Microbiology
Cell Cycle Arrest
11%
Cell Cycle Checkpoint
11%
Cycline
11%
Cytostasis
22%
Growth Promotor
11%
Homeostasis
11%
Lymphoma Cell
100%
Promoter Region
11%
Transforming Growth Factor Beta
100%